Insider trade

Aethlon Medical (AEMD): Director had shares withheld for tax 436 shares

Nicolas Gikakis, Director at Aethlon Medical, reported a tax withholding of 436 shares.

436
Shares · @ $6.52
Traded
Sep 30, 2026
Filed
Oct 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Sep 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 11, 2026, Aethlon Medical, Inc. (the “Company”) entered into amendments to the employment agreements of James B. Frakes, the Company’s Chief Executive Officer and Chief Financial Officer, and Steven P. LaRosa, M.D., the Company’s Chief Medical Officer (collectively, the “Amendments”).”
  3. Sep 17, 2026Company filing · Form 8-K · Material agreement, Change of controlControl of the company changed hands, and signed an important agreement (and 1 more item)“On September 17, 2026, the Company and North Immunology issued a joint press release announcing the entry into the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.”

What came next

  1. Oct 1, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.”
  2. Oct 7, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  3. Oct 13, 20265% stakeJANE STREET GROUP, LLC reported a passive stake (13G) of 5.0%
  4. Nov 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aethlon Medical

For Aethlon Medical, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AEMD page.

How this filing works

Explore the data

Common questions

Which Aethlon Medical (AEMD) insider traded, and how much?

Nicolas Gikakis, Director at Aethlon Medical, reported a tax withholding of 436 shares. At $6.52.

When did it happen, and when was it made public?

Traded: Sep 30, 2026. Filed: Oct 15, 2026. That is 15 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Aethlon Medical recently?

For Aethlon Medical, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the AEMD page.

Does this mean AEMD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Aethlon Medical

Everything OQRO holds on this company is on its AEMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data